SORBI, Claudia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.983
EU - Europa 4.793
AS - Asia 3.644
SA - Sud America 572
AF - Africa 110
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 4
Totale 17.136
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.807
IT - Italia 1.172
GB - Regno Unito 1.055
SG - Singapore 1.027
CN - Cina 904
SE - Svezia 644
DE - Germania 605
VN - Vietnam 464
HK - Hong Kong 453
BR - Brasile 437
FI - Finlandia 296
RU - Federazione Russa 230
FR - Francia 183
KR - Corea 129
UA - Ucraina 125
BD - Bangladesh 124
IN - India 115
TR - Turchia 104
CA - Canada 98
BE - Belgio 92
NL - Olanda 73
BG - Bulgaria 70
ID - Indonesia 55
IE - Irlanda 50
MX - Messico 45
JP - Giappone 43
AR - Argentina 40
PL - Polonia 37
RO - Romania 33
LT - Lituania 29
IQ - Iraq 28
IR - Iran 28
EC - Ecuador 24
ES - Italia 23
NZ - Nuova Zelanda 23
AT - Austria 22
EG - Egitto 22
CO - Colombia 19
ZA - Sudafrica 19
AE - Emirati Arabi Uniti 18
TW - Taiwan 18
CL - Cile 17
IL - Israele 17
VE - Venezuela 15
PK - Pakistan 13
KE - Kenya 12
NO - Norvegia 11
CH - Svizzera 10
KZ - Kazakistan 10
MA - Marocco 10
MY - Malesia 10
TH - Thailandia 10
UZ - Uzbekistan 10
PH - Filippine 9
SA - Arabia Saudita 9
DZ - Algeria 8
TN - Tunisia 8
AU - Australia 7
CZ - Repubblica Ceca 7
NG - Nigeria 7
AZ - Azerbaigian 6
CI - Costa d'Avorio 6
JO - Giordania 6
NI - Nicaragua 6
NP - Nepal 6
CR - Costa Rica 5
JM - Giamaica 5
PE - Perù 5
PY - Paraguay 5
UY - Uruguay 5
BO - Bolivia 4
BY - Bielorussia 4
DK - Danimarca 4
EU - Europa 4
HN - Honduras 4
LB - Libano 4
PS - Palestinian Territory 4
SN - Senegal 4
AL - Albania 3
BH - Bahrain 3
ET - Etiopia 3
LU - Lussemburgo 3
PR - Porto Rico 3
UG - Uganda 3
AO - Angola 2
DO - Repubblica Dominicana 2
EE - Estonia 2
HU - Ungheria 2
MM - Myanmar 2
OM - Oman 2
RS - Serbia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TG - Togo 2
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BN - Brunei Darussalam 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
Totale 17.114
Salva come PNG Salva come JPEG
Città #
Ashburn 687
Santa Clara 656
Southend 644
Singapore 632
Fairfield 519
Hong Kong 430
Chandler 389
San Jose 370
Woodbridge 353
Ann Arbor 329
Munich 324
Chicago 305
Hefei 282
Nyköping 280
Houston 275
Seattle 259
New York 240
Jacksonville 224
Helsinki 218
Beijing 205
Wilmington 193
Modena 190
Dearborn 189
Cambridge 187
Los Angeles 177
Council Bluffs 151
London 150
Ho Chi Minh City 146
Hanoi 105
Seoul 98
Brussels 91
Milan 90
Salt Lake City 83
The Dalles 78
Sofia 66
San Diego 62
Eugene 53
Princeton 53
Elk Grove Village 52
Lauterbourg 50
Bologna 47
Dublin 47
Izmir 46
Orem 45
São Paulo 44
Buffalo 40
Moscow 40
Tampa 40
Tokyo 40
Dallas 39
Amsterdam 36
Toronto 35
Fremont 34
Da Nang 33
Jakarta 33
Rome 32
Shanghai 29
Frankfurt am Main 28
Redwood City 28
Boardman 26
Bremen 25
Warsaw 25
Mexico City 24
Auckland 23
Turku 23
Sochi 22
Sterling 20
Yalova 20
Brooklyn 19
Columbus 19
Phoenix 19
Reggio Emilia 19
Chennai 18
Mumbai 18
Augusta 17
Norwalk 17
Haiphong 16
Parma 16
Philadelphia 16
Atlanta 15
Grafing 15
Jyväskylä 15
Montreal 15
Denver 14
Guangzhou 14
San Francisco 14
Boston 13
Des Moines 13
Kent 13
Lancaster 13
Naples 13
Paris 13
Stockholm 13
Baghdad 12
Hillsboro 12
Horia 12
Leawood 12
Manchester 12
Zanjan 12
Dhaka 11
Totale 11.279
Salva come PNG Salva come JPEG
Nome #
1,3-Dioxolane-Based Ligands Incorporating a Lactam or Imide moiety: Structure-Affinity/Activity Relationship at alpha1–Adrenoceptor subtypes and at 5-HT1A Receptors 750
(2,2-difenil-[1,3]-diossolan-4ilmetil)-(3-fenil-propil)-ammina: nuovo agonista parziale del recettore serotoninergico 5-HT1A 644
1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity 581
1,3-Dioxolane-Based Ligands as a Novel Class of Alpha1-Adrenoceptor Antagonists 528
1,3-Dioxolane-Based Ligands as Rigid Analogues ofNaftopidil: Structure–Affinity/Activity Relationships at a1and 5-HT1A Receptors 498
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 453
1,3-dioxolane-based ligands in the search for alpha1-adrenergic antagonists. 449
Enantiomeric resolution of [(2,2-diphenyl-1,3-dioxolan-4-yl)methyl](2-phenoxyethyl)amine, a potent α1and 5-HT1Areceptor ligand: an in vitro and computational study 447
(2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenylpropyl)-amine: a Potent and Selective 5-HT1A Receptor Agonist 446
Discovery of a new 5-HT1A receptor agonist, acting ‘in vivo’ in a rat model of anxiety and depression 428
A New and Versatile Synthesis of 1,3-Dioxan-5-yl-pyrimidine and Purine Nucleoside Analogues 394
A homology modelling-driven study leading to the discovery of the first mouse trace amine-associated receptor 5 (TAAR5) antagonists 379
Discovery Of New Sigma-2 Receptor Agonist Endowed With Antiproliferative Activity 367
Synthesis, biological evaluation and molecular modeling of 1-oxa-4-thiaspiro- and 1,4-dithiaspiro[4.5]decane derivatives as potent and selective 5-HT1A receptor agonists 351
Structure-Activity Relationship within a new series of σ1 and σ2 receptor ligands: identification of a novel σ2R agonist (BS148) with selective toxicity against metastatic melanoma 341
Diastereoselective Synthesis of (1,3-Dioxan-4-yl)pyrimidine and Purin Nucleoside Analogues 340
Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α1 and 5-HT1A receptors 335
Synthesis and structure-activity relationships of 1-aralkyl-4- benzylpiperidine and 1-aralkyl-4-benzylpiperazine derivatives as potent σ ligands 331
Discovery of a new series of 5-HT1A receptor agonists 330
Synthesis of 6-O-methotrexylhyaluronan as a drug delivery system 329
Investigation of the effect of different linker chemotypes on the inhibition of histone deacetylases (HDACs) 309
Synthesis and biological evaluation of 1,3-dioxolane-based 5-HT 1A receptor agonists for CNS disorders and neuropathic pain 304
Scouting Sigma Receptor Ligands As New Tools For The Treatment Of Neurodegenerative Diseases And Cancer 302
DAT atypical inhibitors as novel antipsychotic drugs 299
Synthesis, structural characterization and biological evaluation of 4′-C-methyl- and phenyl-dioxolane pyrimidine and purine nucleosides 294
BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting 289
Exhaustive CoMFA and CoMSIA analyses around different chemical entities: A ligand-based study exploring the affinity and selectivity profiles of 5-HT1A ligands 276
Synthesis, biological evaluation and molecular modelling of 1-oxa-4-thiaspiro- and 1,4-dithiaspiro[4.5]decane derivatives as potent and selective 5-HT1A receptor agonists 275
Transacetalization of Acetals with Butane-1,2,4-triol Using Cobalt(II) Chloride and Chlorotrimethylsilane 270
Structure-activity relationship at alpha-adrenergic receptors within a series of imidazoline analogues of cirazoline 269
Synthesis and Structure-Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands 264
Synthesis of 5-Methyl-1,3-oxathiolane-based Nucleoside Analogues as Potential Antiviral Agents 258
Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer 250
Structure Activity Relationships at 5-HT1A receptors within a novel series of 4-alkyl-1-arylpiperazine derivatives 244
Pyrrolidine Derivatives as New Ligands for 5-HT1A Receptors 244
Novel Dithiolane-Based Ligands Combining Sigma and NMDA Receptor Interactions as Potential Neuroprotective Agents 244
Synthesis, enantiomeric separation and docking studies of spiropiperidine analogues as ligands of the nociceptin/orphanin FQ receptor 239
Effect of the rigidification of propranolol, a mixed β-adrenoceptor and 5-HT1AR antagonist 236
Identification of a Potent and Selective 5-HT1AReceptor Agonist with In Vitro and In Vivo Antinociceptive Activity 236
Constrained 1,4-dialkylpiperazines as monoamine transporters inhibitors for cocaine-related abuse 233
Synthesis, absolute configuration and antimuscarinic activity of the enantiomers of [1-(2,2-diphenyl-[1,3]dioxolan-4-yl)-ethyl]dimethyl-amine 227
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group 220
Effect of the replacement of the o-methoxyphenyl moiety with nitrogen-containing aromatic rings within N-phenyl-piperazine and phenoxy-ethylamine-based 1,3-dioxo/oxathio/dithiolanes as α1 and 5-HT1A receptor ligands 204
Synthesis, structural characterization and pharmacological evaluation of spiroxatrine analogs as potential nociceptin/orphanin FQ receptor ligands 204
Novel S1R agonists counteracting NMDA excitotoxicity and oxidative stress: A step forward in the discovery of neuroprotective agents 201
Derivati 1,3-Diossanici come Antagonisti Muscarinici 201
1,3-Dithiolane as a Privileged Scaffold in Bioactive Derivatives: Chiral Resolution and Assignment of Absolute Configuration 196
Synthesis and biological evaluation of Hsp90/HDAC6 dual inhibitors bearing a 2-amino-pyrrolopyrimidine and purine scaffold as potential anticancer drugs to treat prostate cancer 188
Spiroxatrine derivatives towards 5-HT1A receptor selectivity 188
Relazioni struttura-attività in una nuova serie di ligandi alpha1-adrenergici e 5-HT1A serotoninergici a struttura 2,2-difenil-[1,3]diossolanica 186
Synthesis and structural characterization of spiroxatrine derivatives as potential non-peptide ligands for NOP receptor 184
IDENTIFICATION OF POTENT 1,3-DIOXOLANE-BASED 5-HT1A RECEPTOR AGONISTS FOR THE TREATMENTS OF CNS DISORDERS AND PAIN 184
Synthesis and pharmacological evaluation of Spiroxatrine derivatives as potential ligands for NOP receptor 177
Nuova Serie di Ligandi Sigma a Struttura Piperazinica e Piperidinica 175
TB62, A POTENT 5-HT1A SEROTONERGIC FULL AGONIST, ENDOWED WITH DUAL ANTINOCICEPTIVE AND ANXIOLITIC/ANTIDEPRESSANT ACTIVITY 153
Structure-Activity Relationships at alpha1-Adrenoceptor Subtypes within a New Series of 1,3-Dioxolane Derivatives 143
Insights into the Structural Conformations of the Tau Protein in Different Aggregation Status 119
Farmaci attivi sul sistema nervoso adrenergico 86
Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate Cancer 16
Totale 17.308
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.628
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.628
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.192 64 106 77 90 49 95 38 65 175 86 206 141
2022/20231.406 221 168 114 151 147 163 42 107 163 46 59 25
2023/2024948 20 51 99 103 216 86 58 126 9 38 69 73
2024/20253.334 161 41 72 163 487 443 472 285 323 156 319 412
2025/20265.639 370 223 462 789 1.069 341 671 289 481 421 277 246
2026/2027138 138 0 0 0 0 0 0 0 0 0 0 0
Totale 17.308